Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target.
Saved in:
| Title: | Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target. |
|---|---|
| Authors: | Kang JL; Department of Neurosurgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Department of Neurosurgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China., Xu YJ; Department of Oncology, Henan Provincial People's Hospital, Zhengzhou, China., Zhao QT; Biotherapy Center and Cancer Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Zhang B; Department of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China., Xu X; Department of Neurosurgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China., Yang B; Department of Neurosurgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. |
| Source: | Oncology research [Oncol Res] 2026 Jun 16; Vol. 34 (7), pp. 23. Date of Electronic Publication: 2026 Jun 16 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
